Filing Details
- Accession Number:
- 0000874716-23-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-31 17:17:05
- Reporting Period:
- 2023-08-29
- Accepted Time:
- 2023-08-31 17:17:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1389046 | F James Polewaczyk | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-29 | 2,627 | $68.75 | 18,665 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-29 | 706 | $141.60 | 19,371 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-29 | 7,151 | $141.60 | 26,522 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-29 | 560 | $178.26 | 27,082 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-29 | 5,865 | $178.26 | 32,947 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-29 | 500 | $508.96 | 32,447 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 2,545 | $509.32 | 29,902 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 6,186 | $510.38 | 23,716 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 3,318 | $510.47 | 20,398 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 7,473 | $511.03 | 12,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 2,887 | $511.22 | 10,038 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2023-08-29 | 2,627 | $0.00 | 2,627 | $68.75 |
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2023-08-29 | 706 | $0.00 | 706 | $141.60 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2023-08-29 | 7,151 | $0.00 | 7,151 | $141.60 |
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2023-08-29 | 560 | $0.00 | 560 | $178.26 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2023-08-29 | 5,865 | $0.00 | 5,865 | $178.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-13 | No | 4 | M | Direct | |
| 0 | 2027-02-13 | No | 4 | M | Direct | |
| 0 | 2027-02-13 | No | 4 | M | Direct | |
| 0 | 2028-02-13 | No | 4 | M | Direct | |
| 0 | 2028-02-13 | No | 4 | M | Direct |
Footnotes
- Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023.
- Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
- Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
- Grant of option to buy 7,151 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
- Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023.
- Grant of option to buy 5,865 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.
Billionaire Hedge Funds
